BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8633467)

  • 21. In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck.
    Waters GS; Burke GJ; Corley JH; Wei JP
    Am Surg; 1997 Feb; 63(2):195-8. PubMed ID: 9012436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of mediastinal parathyroid adenoma in recurrent postoperative hyperparathyroidism with Tc-99m sestamibi SPECT.
    Neumann DR; Esselstyn CB; Eastwood J; Rice TW
    Clin Nucl Med; 1995 Feb; 20(2):175. PubMed ID: 7720311
    [No Abstract]   [Full Text] [Related]  

  • 23. Parathyroid imaging--current status and future prospects.
    Potchen EJ
    J Nucl Med; 1992 Oct; 33(10):1807-9. PubMed ID: 1403147
    [No Abstract]   [Full Text] [Related]  

  • 24. Intrathoracic parathyroid adenoma.
    Shende MR; Pusca SV; Quinlan DP; Bolanowski PJ; Donahoo JS
    Ann Thorac Surg; 2004 Feb; 77(2):724. PubMed ID: 14759477
    [No Abstract]   [Full Text] [Related]  

  • 25. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
    Johnston LB; Carroll MJ; Britton KE; Lowe DG; Shand W; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
    Wei JP; Burke GJ; Mansberger AR
    Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent or residual hyperparathyroidism and thyroid cancer effectively evaluated with scintigraphy.
    Brenner ME; Jacene HA
    Otolaryngol Clin North Am; 2008 Dec; 41(6):1117-33, viii-ix. PubMed ID: 19040973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism].
    Paillahueque G; Massardo T; Barberán M; Ocares G; Gallegos I; Toro L; Araya AV
    Rev Med Chil; 2017 Aug; 145(8):1021-1027. PubMed ID: 29189860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of adenoma and parathyroid hyperplasia using subtraction scintigraphy with thallium 201-Tc99m].
    González P; Pumarino H; Gac A; Saffie A; Olea E; Sirandoni G; Campino C; Garcés N
    Rev Med Chil; 1988 Jul; 116(7):633-9. PubMed ID: 2855755
    [No Abstract]   [Full Text] [Related]  

  • 30. The value of SPECT/CT 99mTc-sestamibi scintigraphy in the diagnosis of ectopic parathyroid adenoma.
    Radan L; Gorenberg M
    Isr Med Assoc J; 2009 Jul; 11(7):448. PubMed ID: 19911503
    [No Abstract]   [Full Text] [Related]  

  • 31. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy.
    Billotey C; Sarfati E; Aurengo A; Duet M; Mündler O; Toubert ME; Rain JD; Najean Y
    J Nucl Med; 1996 Nov; 37(11):1773-8. PubMed ID: 8917173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium Tc 99m sestamibi scan for localizing abnormal parathyroid glands after previous neck operations: preliminary experience in reoperative cases.
    Majors JD; Burke GJ; Mansberger AR; Wei JP
    South Med J; 1995 Mar; 88(3):327-30. PubMed ID: 7886531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid imaging with 99m Tc-sestamibi.
    Gordon BM; Gordon L; Hoang K; Spicer KM
    AJR Am J Roentgenol; 1996 Dec; 167(6):1563-8. PubMed ID: 8956598
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow uptake in parathyroid scintigraphy is a consequence of extremely high parathyroid hormone levels.
    Koç ZP; Balcı TA; Dogukan A
    Endocr Pract; 2013; 19(2):202-5. PubMed ID: 23186971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (99m)Tc MIBI SPECT findings in parathyromatosis--a rare entity causing recurrent hyperparathyroidism.
    Pinnamaneni N; Shankar PR; Muthukrishnan A
    Clin Nucl Med; 2013 Nov; 38(11):e443-5. PubMed ID: 23603581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia.
    Arbab AS; Koizumi K; Hemmi A; Toyama K; Arai T; Yoshitomi T; Araki T
    Ann Nucl Med; 1997 Feb; 11(1):45-9. PubMed ID: 9095323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of sequential double tracer subtraction and SPECT parathyroid imaging in the precise localization of a low mediastinal parathyroid adenoma successfully removed surgically.
    Rubello D; Pagetta C; Piotto A; Casara D; Zonzin GC; Muzzio PC; Pelizzo MR
    Clin Nucl Med; 2004 Oct; 29(10):662-3. PubMed ID: 15365449
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [99mTc-MIBI scintigraphy for the detection of parathyroid lesions in patients with hyperparathyroidism].
    Okuda I; Saitoh K; Maruno T; Hatano O; Takizawa Y; Murata H; Koyano H; Ozawa Y; Shimizu T; Shishiba Y
    Kaku Igaku; 1995 Jun; 32(6):557-62. PubMed ID: 7674565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of 99mTc-MIBI scintigraphy in diagnostic localization of hyperparathyroidism. A prospective study].
    Schoenemann B; Wurm K; Bihl H; Merkle P
    Chirurg; 1996 Jan; 67(1):32-6. PubMed ID: 8851673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.